GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype.
- Authors
- Arya, Ravindra; Spaeth, Christine; Gilbert, Donald L; Leach, James L; Holland, Katherine D
- Year
- 2017
- Journal
- Epileptic disorders : international epilepsy journal with videotape
- PMID
- 28202424
- DOI
- 10.1684/epd.2017.0888
We describe a case of GNAO1-associated epilepsy and chorea in a patient with a de novo pathogenic mutation. This patient is unique in being the first reported male with this phenotype, and we propose that this genetic variant may represent a mutation hotspot that characterizes a unique phenotype. This 5.2-years-old boy presented with seizures, chorea, and severe global developmental delay. Brain imaging showed progressive diffuse cerebral atrophy. EEG monitoring revealed multifocal and diffuse discharges, along with generalized-onset seizures. Genetic testing found a de novo pathogenic variant in the GNAO1 gene (c.607G>A; p.Gly203Arg). A review of the literature showed two other patients with similar phenotype and the same genetic variant. In contrast, other patients with neurological involvement had private mutations in the GNAO1 gene. The neurological phenotypes associated with GNAO1 mutations appear to lie on a spectrum, and it is possible that the c.607G>A (p.Gly203Arg) variant characterizes a phenotype with both severe epilepsy and chorea. [Published with video sequence on www.epilepticdisorders.com].
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Deciphering a mechanistic basis for the pathological effect of the GNAO1 E246K variant in neurodevelopmental disorder. | Sadiya I et al. | β | 2026 | β |
| Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder. | Shomer I et al. | β | 2025 | β |
| Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation. | Lasa-Aranzasti A et al. | β | 2024 | β |
| CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the <i>Gnao1</i> for safety studies of RNA therapeutics. | Polikarpova AV et al. | β | 2023 | β |
| [Encephalopathy GNAO1]. | Bobylova MY et al. | β | 2023 | β |
| GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey. | JoJo Yang QZ et al. | β | 2023 | β |
| GNAO1-related Neurodevelopmental Disorder Presenting as Acute Encephalitis Syndrome: A Phenotypic Expansion. | Panda PK et al. | β | 2023 | β |
| Phenotypes in children with <i>GNAO1</i> encephalopathy in China. | Li Y et al. | β | 2023 | β |
| Both subthalamic and pallidal deep brain stimulation are effective for <i>GNAO1</i>-associated dystonia: three case reports and a literature review. | Liu Y et al. | β | 2022 | β |
| DBS emergency surgery for treatment of dystonic storm associated with rhabdomyolysis and acute colitis in DYT-GNAO1. | Chaib H et al. | β | 2022 | β |
| Mice with monoallelic <i>GNAO1</i> loss exhibit reduced inhibitory synaptic input to cerebellar Purkinje cells. | Feng H et al. | β | 2022 | β |
| Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling. | Galosi S et al. | β | 2022 | β |
| Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. | Silachev D et al. | β | 2022 | β |
| Restoration of the GTPase activity and cellular interactions of GΞ±<sub>o</sub> mutants by Zn<sup>2+</sup> in <i>GNAO1</i> encephalopathy models. | Larasati YA et al. | β | 2022 | β |
| Genome-wide association study of stimulant dependence. | Cox J et al. | β | 2021 | β |
| Mice With Monoallelic <i>GNAO1</i> Loss Exhibit Reduced Inhibitory Synaptic Input To Cerebellar Purkinje Cells | Feng H et al. | β | 2021 | β |
| Phenotypes of <i>GNAO1</i> Variants in a Chinese Cohort. | Yang X et al. | β | 2021 | β |
| Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey. | Axeen E et al. | β | 2021 | β |
| Chorea in children: etiology, diagnostic approach and management. | Baizabal-Carvallo JF et al. | β | 2020 | β |
| Genomic Analysis of Korean Patient With Microcephaly. | Lee J et al. | β | 2020 | β |
| Mice with <i>GNAO1</i> R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone. | Larrivee CL et al. | β | 2020 | β |
| Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis. | Kim SY et al. | β | 2020 | β |
| Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes. | Feng H et al. | β | 2019 | β |
| Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review. | Schirinzi T et al. | β | 2019 | β |
| Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region. | Kelly M et al. | β | 2019 | β |
| A mechanistic review on GNAO1-associated movement disorder. | Feng H et al. | β | 2018 | β |
| GNAO1 Mutation-Induced Pediatric Dystonic Storm Rescue With Pallidal Deep Brain Stimulation. | Honey CM et al. | β | 2018 | β |
| Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms. | Abela L et al. | β | 2018 | β |
| Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing. | Bruun TUJ et al. | β | 2018 | β |
| [Recurrent convulsion and pulmonary infection complicated by psychomotor retardation in an infant]. | Xiong J et al. | β | 2018 | β |
| Emerging Monogenic Complex Hyperkinetic Disorders. | Carecchio M et al. | β | 2017 | β |